Αποτελέσματα αναζήτησης - David M. Charytan
- Εμφανίζονται 1 - 20 Αποτελέσματα από 64
- Μετάβαση στην Επόμενη Σελίδα
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
Neutralization of Circulating Vascular Endothelial Growth Factor (VEGF) by Anti-VEGF Antibodies and Soluble VEGF Receptor 1 (sFlt-1) Induces Proteinuria από Hikaru Sugimoto, Yuki Hamano, David M. Charytan, Dominic Cosgrove, Mark W. Kieran, Akulapalli Sudhakar, Raghu Kalluri
Έκδοση 2003Artigo -
10
-
11
-
12
-
13
-
14
-
15
-
16
Outcomes with revascularization and medical therapy in patients with coronary disease and chronic kidney disease: A meta-analysis από Alexandre Leszek, Lauriane Poli, Stéphanie Zbinden, Lucas C. Godoy, Jean‐Luc Reny, Michael E. Farkouh, David M. Charytan, Thomas A. Mavrakanas
Έκδοση 2022Revisão -
17
-
18
Loss of Hypoxia-Inducible Factor Prolyl Hydroxylase Activity in Cardiomyocytes Phenocopies Ischemic Cardiomyopathy από Javid J. Moslehi, Yoji Andrew Minamishima, Jianru Shi, Donna Neuberg, David M. Charytan, Robert F. Padera, Sabina Signoretti, Ronglih Liao, William G. Kaelin
Έκδοση 2010Artigo -
19
Increased concentration of circulating angiogenesis and nitric oxide inhibitors induces endothelial to mesenchymal transition and myocardial fibrosis in patients with chronic kidne... από David M. Charytan, Robert F. Padera, Alexander M. Helfand, Michael Zeisberg, Xingbo Xu, Xiaopeng Liu, Jonathan Himmelfarb, Angeles Cinelli, Raghu Kalluri, Elisabeth M. Zeisberg
Έκδοση 2014Artigo -
20
Εργαλεία αναζήτησης:
Σχετικά θέματα
Medicine
Internal medicine
Kidney disease
Cardiology
Intensive care medicine
Endocrinology
Diabetes mellitus
Myocardial infarction
Renal function
Type 2 diabetes
Dialysis
Confidence interval
Canagliflozin
Coronary artery disease
Disease
Hazard ratio
Randomized controlled trial
Heart failure
Pathology
Urology
Alternative medicine
Environmental health
Placebo
Population
Hemodialysis
Acute kidney injury
Albuminuria
Biology
Clinical trial
Engineering